BofA analyst Craig Siegenthaler raised the firm’s price target on CME Group (CME) to $210 from $204 and keeps a Neutral rating on the shares. Q3 has been defined in the exchange/market structure vertical by the ebbing of equity volatility, which has benefited the listings set-up at the expense of equity volumes, the analyst tells investors in a preview note. The subdued volatility has allowed for green shoots in the listings businesses of IntercontinentalExchange (ICE) and Nasdaq (NDAQ), as the Arm (ARM) IPO in September was the largest since 2021 at $55B, the analyst noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CME:
- CME Group to launch Micro Henry Hub futures and options on November 6
- CME Group to launch Cobalt Hydroxide futures on October 23
- CME Group and DTCC granted regulatory approval for cross-margining arrangement
- CME Group to launch options on Micro Gold futures, pending review
- CME Group announces record ADV in August of 12,291 contracts